Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (21)
Elisabete Paschoal, Tiffany E. Gooden, Rodrigo D. Olmos, Paulo A. Lotufo, Isabela M. Benseñor, Semira Manaseki-Holland, Gregory Y. H. Lip, G. Neil Thomas, Kate Jolly, Emma Lancashire, Deirdre A. Lane, Sheila Greenfield, Alessandra C. Goulart, Ajini Arasalingam, Abi Beane, Peter Brocklehurst, Kar Keung Cheng, Wahbi El-Bouri, Mei Feng, Yutao Guo, Mahesan Guruparan, Gustavo Gusso, Rashan Haniffa, Lindsey Humphreys, Sue Jowett, Chamira Kodippily, Balachandran Kumarendran, Xuewen Li, Yan-guang Li, Trudie Lobban, David Moore, Krishnarajah Nirantharakumar, Paskaran Pirasanth, Uruthirakumar Powsiga, Carla Romagnolli, Itamar S. Santos, Alena Shantsila, Vethanayagan Antony Sheron, Kanesamoorthy Shribavan, Isabelle Szmigin, Kumaran Subaschandren, Rajendra Surenthirakumaran, Meihui Tai, Bamini Thavarajah, Timo Toippa, Ana C. Varella, Hao Wang, Jingya Wang, Hui Zhang & Jiaoyue Zhong. (2022) Health care professionals’ perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study. BMC Cardiovascular Disorders 22:1.
Crossref
Crossref
Mark H. Eckman, Ruth Wise, Carol Knochelmann, Rachael Mardis, Sharon Wright, Ashish Gummadi, Estrelita Dixon, Richard Becker, Daniel P. Schauer, Matthew L. Flaherty, Alexandru Costea, Dawn Kleindorfer, Rob Ireton, Pete Baker, Brett M. Harnett, Adeboye Adejare, Anthony C. Leonard, Heidi Sucharew, Amy Costanzo, Lora Arduser & John Kues. (2022) Electronic health record-embedded decision support to reduce stroke risk in patients with atrial fibrillation – Study protocol. American Heart Journal 247, pages 42-54.
Crossref
Crossref
Eyob Alemayehu Gebreyohannes, Sandra Salter, Leanne Chalmers, Luke Bereznicki & Kenneth Lee. (2020) Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence. American Journal of Cardiovascular Drugs 21:4, pages 419-433.
Crossref
Crossref
Katie B. Tellor, Michael D. Lloyd, Timothy J. Hartman & Anastasia L. Armbruster. (2019) Evaluation of Guideline-Directed Medical Therapy for the Reduction of Stroke and Systemic Embolism in Hospitalized Patients with Nonvalvular Atrial Fibrillation. Hospital Pharmacy 56:1, pages 26-31.
Crossref
Crossref
Mei Wang, Anne Holbrook, Munil Lee, Jiayu Liu, Alvin Leenus, Nora Chen, Lawrence Mbuagbaw & Lehana Thabane. (2020) Barriers and facilitators to optimal oral anticoagulant management: a scoping review. Journal of Thrombosis and Thrombolysis 50:3, pages 697-714.
Crossref
Crossref
Larry R. JacksonIIII, Sunghee Kim, Rosalia Blanco, Laine Thomas, Jack Ansell, Gregg C. Fonarow, Bernard J. Gersh, Alan S. Go, Peter R. Kowey, Kenneth W. Mahaffey, Elaine M. Hylek, Eric D. Peterson & Jonathan P. Piccini. (2020) Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). American Heart Journal 226, pages 85-93.
Crossref
Crossref
Ruth V. Pritchett, Joanne L. Clarke, Kate Jolly, Danielle Clarkesmith, Danai Bem, Grace M. Turner, G. Neil Thomas & Deirdre A. Lane. (2020) Clinicians’ views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis. PLOS ONE 15:5, pages e0232484.
Crossref
Crossref
Hee Tae Yu, Pil-Sung Yang, Jinseub Hwang, Soorack Ryu, Eunsun Jang, Tae-Hoon Kim, Jae-Sun Uhm, Jong-Youn Kim, Hui-Nam Pak, Moon-Hyoung Lee, Gregory Y.H. Lip & Boyoung Joung. (2020) Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation. Korean Circulation Journal 50:3, pages 267.
Crossref
Crossref
Josephine Gibson & Stephanie Jones. 2019. Stroke Nursing. Stroke Nursing
53
74
.
Hyunmee Kim, Hyeongsoo Kim, Seong-Kyung Cho, Jin-Bae Kim, Boyoung Joung & Changsoo Kim. (2019) Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation. Korean Circulation Journal 49:3, pages 252.
Crossref
Crossref
Larry R. JacksonIIII, Sunghee Kim, Peter Shrader, Rosalia Blanco, Laine Thomas, Michael D. Ezekowitz, Jack Ansell, Gregg C. Fonarow, Bernard J. Gersh, Alan S. Go, Peter R. Kowey, Kenneth W. Mahaffey, Elaine M. Hylek, Eric D. Peterson & Jonathan P. PicciniSr.Sr.. (2018) Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Journal of Thrombosis and Thrombolysis 46:4, pages 435-439.
Crossref
Crossref
Gemma Mas Dalmau, Elisenda Sant Arderiu, María Belén Enfedaque Montes, Ivan Solà, Sandra Pequeño Saco & Pablo Alonso Coello. (2017) Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review. BMC Family Practice 18:1.
Crossref
Crossref
Isuru Induruwa, Nicholas R. Evans, Ayesha Aziz, Snigdha Reddy, Kayvan Khadjooi & Roman Romero-Ortuno. (2017) Clinical frailty is independently associated with non-prescription of anticoagulants in older patients with atrial fibrillation. Geriatrics & Gerontology International 17:11, pages 2178-2183.
Crossref
Crossref
Lauren E. Thompson, Thomas M. Maddox, Lanyu Lei, Gary K. Grunwald, Steven M. Bradley, Pamela N. Peterson, Frederick A. Masoudi, Alexander Turchin, Yang Song, Gheorghe Doros, Melinda B. Davis & Stacie L. Daugherty. (2017)
Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR
®
) PINNACLE Registry
. Journal of the American Heart Association 6:7.
Crossref
Crossref
Lucas N. Marzec, Jingyan Wang, Nilay D. Shah, Paul S. Chan, Henry H. Ting, Kensey L. Gosch, Jonathan C. Hsu & Thomas M. Maddox. (2017) Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation. Journal of the American College of Cardiology 69:20, pages 2475-2484.
Crossref
Crossref
Yishen Wang & Beata Bajorek. (2016) Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals’ views. International Journal of Clinical Pharmacy 38:4, pages 985-995.
Crossref
Crossref
John K. Abdou, Vivian Auyeung, Jignesh P. Patel & Roopen Arya. (2016) Adherence to long-term anticoagulation treatment, what is known and what the future might hold. British Journal of Haematology 174:1, pages 30-42.
Crossref
Crossref
Deirdre A. Lane, Luis Aguinaga, Carina Blomström-Lundqvist, Giuseppe Boriani, Gheorge-Andrei Dan, Mellanie True Hills, Elaine M. Hylek, Stephen A. LaHaye, Gregory Y.H. Lip, Trudie Lobban, John Mandrola, Pamela J. McCabe, Susanne S. Pedersen, Ron Pisters, Simon Stewart, Kathryn Wood, Tatjana S. Potpara, Bulent Gorenek, Jamie Beth Conti, Roberto Keegan, Suzannah Power, Jeroen Hendriks, Philippe Ritter, Hugh Calkins, Francesco Violi & Jodie Hurwitz. (2015) Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace 17:12, pages 1747-1769.
Crossref
Crossref
Stuart G Nicholls, Jamie C Brehaut, Rubab G Arim, Kelly Carroll, Richard Perez, Kaveh G Shojania, Jeremy M Grimshaw & Roy M Poses. (2014) Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians. Thrombosis Journal 12:1.
Crossref
Crossref
Emily C. O’Brien, DaJuanicia N. Simon, Larry A. Allen, Daniel E. Singer, Gregg C. Fonarow, Peter R. Kowey, Laine E. Thomas, Michael D. Ezekowitz, Kenneth W. Mahaffey, Paul Chang, Jonathan P. Piccini & Eric D. Peterson. (2014) Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). American Heart Journal 168:4, pages 487-494.
Crossref
Crossref
Mark H. EckmanRuth E. WiseBarbara SpeerMegan SullivanNita WalkerGregory Y.H. LipBrett KisselaMatthew L. FlahertyDawn KleindorferFaisal KhanJohn KuesPeter BakerRobert IretonDave HoskinsBrett M. HarnettCarlos AguilarAnthony LeonardRajan PrakashLora ArduserAlexandru Costea. (2014) Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation. Circulation: Cardiovascular Quality and Outcomes 7:5, pages 680-686.
Crossref
Crossref